Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [843]
News [2102]
Articles [21]
Editorials [1]
Conferences [129]
elearning [2]
PARP inhibitor olaparib as treatment for pancreatic cancer patients with BRCA...
Dr Hedy Kindler - University of Chicago, Chicago, USA
PARP inhibitor olaparib as treatment for pancreatic cancer patients with BRCA gene mutations ( Dr Hedy Kindler - University of Chicago, Chicago, USA )
2 Jun 2019
Biomarker analysis from JAVELIN Renal 101: Avelumab plus axitinib versus...
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
Biomarker analysis from JAVELIN Renal 101: Avelumab plus axitinib versus sunitinib in aRCC ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
1 Jun 2019
KEYNOTE-001: Five year data from the phase Ib trial studying pembrolizumab as...
Dr Edward B. Garon - UCLA, Los Angeles, USA
KEYNOTE-001: Five year data from the phase Ib trial studying pembrolizumab as treatment for aNSCLC ( Dr Edward B. Garon - UCLA, Los Angeles, USA )
1 Jun 2019
Ovarian cancer: Current treatments and latest advances
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
Ovarian cancer: Current treatments and latest advances ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )
24 May 2019
Latest in ovarian cancer treatment
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
Latest in ovarian cancer treatment ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )
24 May 2019
Artificial intelligence and treatment decisions
Dr Pratik Shah - Massachusetts Institute of Technology, Cambridge, USA
Artificial intelligence and treatment decisions ( Dr Pratik Shah - Massachusetts Institute of Technology, Cambridge, USA )
24 May 2019
MLL-rearranged acute lymphoblastic leukaemia
Dr Pablo Menéndez - Josep Carreras Leukemia Research Institute, Barcelona, Spain
MLL-rearranged acute lymphoblastic leukaemia ( Dr Pablo Menéndez - Josep Carreras Leukemia Research Institute, Barcelona, Spain )
24 May 2019
Epigenetic expression in T cell leukaemia
Dr Sinisa Dovat - Penn State Cancer Institute, Hershey, USA
Epigenetic expression in T cell leukaemia ( Dr Sinisa Dovat - Penn State Cancer Institute, Hershey, USA )
24 May 2019
Managing metabolism and drug toxicity in acute lymphoblastic leukaemia
Dr Mary Relling - St Jude's Children's Research Hospital, Memphis, USA
Managing metabolism and drug toxicity in acute lymphoblastic leukaemia ( Dr Mary Relling - St Jude's Children's Research Hospital, Memphis, USA )
24 May 2019
Second-line and beyond in mCRC: Optimising the benefit and reducing the risk
Prof Mohamed Salem - Georgetown University Hospital, Washington D.C., USA
Second-line and beyond in mCRC: Optimising the benefit and reducing the risk ( Prof Mohamed Salem - Georgetown University Hospital, Washington D.C., USA )
9 May 2019
Controversies in the management of prostate cancer
Prof Mach Roach III - University of California, San Francisco, USA
Controversies in the management of prostate cancer ( Prof Mach Roach III - University of California, San Francisco, USA )
9 May 2019
Highlights from IGILUC 2019
Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Highlights from IGILUC 2019 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation